OR WAIT null SECS
December 15, 2020
The companies are entering into a license and collaboration agreement for the development and commercialization of Relay’s investigational cancer treatment, RLY-1971, a potent inhibitor of SHP2, a molecule that plays a role in cancer cell survival.
Sterling Pharma Solutions has formed a new strategic partnership with ADC Bio.
December 14, 2020
EUA marks a milestone in COVID-19 vaccine development and is hailed as a turning point in pandemic fight.
December 11, 2020
Committee recommends Emergency Use Authorization of first mRNA-based COVID-19 vaccine; FDA approval is pending.
The European Commission has granted a license for the use of inclisiran (Leqvio) as a treatment of primary hypercholesterolemia or mixed dyslipidaemia in adult patients.
December 09, 2020
The collaboration includes the development, commercialization, and supply of Orgenesis’ pipeline in South Korea and Japan and the development and commercialization of Cure Therapeutics’ pipeline on a global basis.
December 04, 2020
Startup company Vivlion has signed a non-exclusive license agreement with ERS Genomics granting access to CRISPR/Cas9 patent portfolio.
Lonza has formed a long-term, strategic collaboration with a global biopharma company for bioconjugation.
December 03, 2020
Janssen announces rolling submissions for its COVID-19 vaccine with Health Canada and EMA.
The gene therapy increases the ability of retina cells to make a soluble form of CD59, a protein that shields the retina from damage, to prevent additional damage and to preserve vision.